KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nov (NOV) Gains from Sales and Divestitures (2016 - 2025)

Nov's Gains from Sales and Divestitures history spans 16 years, with the latest figure at $2.9 million for Q4 2025.

  • On a quarterly basis, Gains from Sales and Divestitures fell 5.56% to $2.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.9 million, a 5.56% decrease, with the full-year FY2025 number at $2.9 million, down 5.56% from a year prior.
  • Gains from Sales and Divestitures hit $2.9 million in Q4 2025 for Nov, down from $3.1 million in the prior quarter.
  • Over the last five years, Gains from Sales and Divestitures for NOV hit a ceiling of $3.1 million in Q4 2024 and a floor of $2.7 million in Q4 2021.
  • Historically, Gains from Sales and Divestitures has averaged $2.9 million across 5 years, with a median of $2.9 million in 2025.
  • Biggest five-year swings in Gains from Sales and Divestitures: decreased 17.25% in 2021 and later increased 7.14% in 2022.
  • Tracing NOV's Gains from Sales and Divestitures over 5 years: stood at $2.7 million in 2021, then increased by 7.14% to $2.9 million in 2022, then rose by 6.35% to $3.0 million in 2023, then grew by 0.78% to $3.1 million in 2024, then decreased by 5.56% to $2.9 million in 2025.
  • Business Quant data shows Gains from Sales and Divestitures for NOV at $2.9 million in Q4 2025, $3.1 million in Q4 2024, and $3.0 million in Q4 2023.